BioSpace News Archive

Neway, LLC, the U.S. leader in value-based dialysis lab care, announced a strategic lab services arrangement with Quest Diagnostics that aims to accelerate dialysis laboratory testing and reduce the laboratory costs of dialysis programs for patients with end-stage renal disease.

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the Jefferies Inaugural Biotech CNS/Neuro Summit in New York City on Wednesday, October 11, 2023.

Rivus Pharmaceuticals Inc. today announced publication in The Lancet Gastroenterology & Hepatology of the results of a Phase 2a metabolic study of HU6, an investigational first-in-class controlled metabolic accelerator (CMA), in patients with nonalcoholic fatty liver disease (NAFLD), also known as metabolic dysfunction-associated steatotic liver disease (MASLD), and a high body mass index (BMI).

GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced that detailed findings from the PATHFINDER study of its multi-cancer early detection (MCED) blood test have been published in The Lancet.

Verisante Technology, Inc. previously announced on September 7, 2023, that it had agreed to convert certain payables owed to Creditors into common shares in the capital of the Company.

GC Biopharma Corp. announced that GC1126A, its drug candidate for Thrombotic Thrombocytopenic Purpura, received an Orphan Drug Designation on September 27 from the U.S. Food and Drug Administration.

Navidea Biopharmaceuticals, Inc. announced that the Listings Qualifications Panel of the Committee for Review of the Board of Directors of the NYSE American LLC upheld the NYSE Regulation staff’s previously announced determination to initiate delisting proceedings with respect to the Company’s common stock.

Spartan Medical Inc., a veteran-owned medical solutions company, is launching a campaign to raise awareness about the consequences of Surgical Site Infections and reduce SSIs in medical centers across the country.

Experic, a contract development and manufacturing organization (CDMO) and clinical supply services company serving the biopharmaceutical industry

In this job market report we’re reviewing life sciences job market movement in Q3 and what to expect for Q4 and beyond.